Active Genomes Expressed Diagnostics Corp — Form D
Active Genomes Expressed Diagnostics Corp of WASHINGTON, DC, a company, filed a Form D exempt-offering notice with the SEC on 2023-02-15. The offering totals $1.8M, of which $250K was reported sold. Industry: Other Technology.
Offering
- Filed: 2023-02-15
- Form: D
- Accession: 0001964994-23-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $1.8M
- Amount sold: $250K
- Remaining: $1.5M
- Minimum investment: $100K
- Investors: 2
- Date of first sale: 2022-12-29
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-473512
Issuer
- Name: Active Genomes Expressed Diagnostics Corp
- CIK: 0001964994
- Entity type: Corporation
- Jurisdiction: DISTRICT OF COLUMBIA
- Incorporated: 2021
- Address: 625 H ST NE, WASHINGTON, DC, 20002
- Phone: (617) 777-7971
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Rachel Zayas | Director | Washington, DC |
| Rachel Zayas | Executive Officer | Washington, DC |
More